Patients with autoimmune conditions are evaluated carefully, because the goal is to modulate inflammation thoughtfully rather than broadly suppress immune function
Human relevance would require sufficient published, peer-reviewed controlled human studies, safety evaluation, pharmacokinetic understanding, toxicology data, and regulatory reviewevidence that has not yet been established at the level required for clinical or consumer-use conclusions
The dosage and frequency are determined by a healthcare provider based on the individual's condition
The 1-3 mg/mL range described in most community protocols sits in the comfortable middle
Our transcriptome data also point to aberrant T cell activation and regulation of IFN production
TB-500 (Thymosin -4 Fragment) TB-500 is a synthetic peptide derived from a functional region of thymosin -4 (TB4)